News
Albumedix Announces Appointment of Gregor Kawaletz as Chief Commercial Officer
Albumedix Ltd., the world leader in recombinant human albumin (rAlb), announced the strengthening of its Executive Leadership with the appointment of Gregor Kawaletz as Chief Commercial Officer, as of June 1st, 2020. This announcement follows the recent appointment of...
News
Sygnature expands capabilities with acquisition of Alderley Oncology
Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, is further strengthening its oncology and immuno-oncology capabilities with the acquisition of Alderley Oncology, a focused in vivo pharmacology service provider which undertakes high quality in vivo...
News
Messe Frankfurt to focus on highlighting strong anti-counterfeiting measures in wake of Covid-19
As demand for medical supplies soars worldwide in the fight against Covid-19, there is a parallel risk of substandard and counterfeit medicines in the global market. With India being one of the world's largest producers of medical supplies, there...
News
WuXi AppTec Appoints Dr. David Chang as CEO of WuXi Advanced Therapies Business Unit
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, announced the appointment of Dr. David Chang as Chief Executive Officer of WuXi Advanced Therapies business unit, WuXi AppTec’s cell and gene therapy Contract...
News
Regeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based Treatments
Regeneron Pharmaceuticals, Inc. and Intellia Therapeutics, Inc. announced an expansion of their existing collaboration to provide Regeneron with rights to develop products for additional in vivo CRISPR/Cas9-based therapeutic targets and for the companies to jointly develop potential products for...
News
Proteostasis Therapeutics Announces In Vitro Data for PTI-129 as Potential Treatment Candidate for COVID-19
Proteostasis Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), announced results from in vitro studies evaluating the use of PTI-129 as a treatment for COVID-19. PTI-129...
News
LabCorp Launches New COVID-19 Clinical Trial Site to Connect Patients With U.S. Research Trials
LabCorp , a leading global life sciences company that is deeply integrated in guiding patient care, announced that Covance, its drug development business, has created COVID-19 Clinical Trial Connect in the U.S., a site designed to help people access...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
